Publisher
Springer International Publishing
Reference17 articles.
1. Abalos RM, Burgos JA, Saunderson P, Sakatani M (2011) Development of therapeutic and prophylactic vaccine against Tuberculosis using monkey and transgenic mice models. Hum Vaccin 7(Suppl):108–114, Epub 2011 Jan 1
2. Anderson P, Doherty TM (2005) The success and failure of BCG–implications for a novel tuberculosis vaccine. Nat Rev Microbiol 3(8):656–662
3. Aronson NE, Santosham M, Comstock GW, Howard RS, Moulton LH, Rhoades ER, Harrison LH (2004) Long-term efficacy of BCG vaccine in American Indians and Alaska Natives: a 60-year follow-up study. JAMA 291(17):2086–2091
4. Biomarkers Working Group (2001) Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 69:89–95
5. Fine PE (1995) Variation in protection by BCG: implications of and for heterologous immunity. Lancet 346:1339–1345